Terug
Dagbereik
€ 12,77
€ 13,53
52-Weeksbereik
€ 7,98
€ 19,51
Volume
101.676
50D / 200D Gem.
€ 15,62
/
€ 14,17
Vorige Slotkoers
€ 13,21
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -17,2 | 0,3 |
| P/B | 3,0 | 2,9 |
| ROE % | -21,0 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 36,50
+172.6%
Low: € 32,00
High: € 40,00
Forward WPA
-€ 1,46
Omzet Sch.
0
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,17
€ 0,17 – € 0,17
|
350 M | 5 |
| FY2029 |
-€ 1,60
-€ 1,60 – -€ 1,60
|
91 M | 2 |
| FY2028 |
-€ 2,18
-€ 3,34 – -€ 1,54
|
5,1 M | 7 |
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -43,67M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-21,04%
ROIC-16,24%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,00
Current Ratio34,13
Interest Coverage-131,05
Waardering
P/E Ratio
-17,21
P/B Ratio2,97
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -48,26M |
| ROE | -21,04% | ROA | -16,74% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -43,67M |
| ROIC | -16,24% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 34,13 |
| Interest Coverage | -131,05 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -17,21 | P/B Ratio | 2,97 |
| P/S Ratio | N/A | PEG Ratio | -3,01 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 830,57M | Enterprise Value | 584,83M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -48,26M | -38,96M | -35,59M | -22,46M | -9,20M |
| EPS (Diluted) | -0,79 | -0,75 | -0,68 | -0,14 | -0,18 |
| Gross Profit | -335.000,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -60,68M | -50,31M | -41,22M | -30,55M | -15,10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 288,23M | 188,27M | 226,30M | 254,36M | 279,92M |
| Total Liabilities | 8,53M | 9,32M | 7,33M | 4,55M | 2,75M |
| Shareholders' Equity | 279,70M | 178,95M | 218,97M | 249,82M | 277,18M |
| Total Debt | 512.000,0 | 624.000,0 | 974.000,0 | 0,0 | 0,0 |
| Cash & Equivalents | 246,25M | 100,79M | 78,42M | 165,96M | 276,78M |
| Current Assets | 285,98M | 154,23M | 164,09M | 168,54M | 279,84M |
| Current Liabilities | 8,38M | 8,95M | 6,70M | 4,55M | 2,75M |